Fidelity Investments’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Fidelity Investments’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-22,701	Closed	-$635K	–	4505
2019 Q3	$635K	Sell	22,701 -810,962	-97%	-$13.1M	﹤0.01%	2488
2019 Q2	$11.8M	Sell	833,663 -513,858	-38%	-$4.89M	﹤0.01%	1827
2019 Q1	$12M	Buy	1,347,521 +10,970	+0.8%	+$89K	﹤0.01%	1796
2018 Q4	$10.1M	Sell	1,336,551 -502,686	-27%	-$8.09M	﹤0.01%	1802
2018 Q3	$38.6M	Sell	1,839,237 -373,745	-17%	-$8.9M	﹤0.01%	1395
2018 Q2	$66.2M	Sell	2,212,982 -95,368	-4%	-$2.6M	0.01%	1144
2018 Q1	$62.6M	Buy	2,308,350 +423,425	+22%	+$12.7M	0.01%	1197
2017 Q4	$54.3M	Sell	1,884,925 -119,110	-6%	-$3.26M	0.01%	1254
2017 Q3	$48.7M	Buy	2,004,035 +31,422	+2%	+$745K	0.01%	1314
2017 Q2	$44M	Buy	+1,972,613	New	+$41.5M	0.01%	1335

Fidelity Investments's DOVA Position: Q4 2019 in Review

Fidelity Investments sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 22,701 shares — an estimated $635K sold.

Fidelity Investments first reported a position in DOVA in Q2 2017 and held it in 10 quarters. The position peaked at $66.2M in Q2 2018. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Fidelity Investments reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Fidelity Investments sold 22,701 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $635K.
Fidelity Investments first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 10 quarters.
Fidelity Investments's Dova Pharmaceuticals, Inc. Common Stock position peaked at $66.2M in Q2 2018.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Fidelity Investments's 13F filing for Q4 2019, filed 7 Feb 2020.